Devices/Recall·openFDA/device

Penumbra, Inc. — Class II: Penumbra System RED 68 Reperfusion Catheter REF: RED68KIT

MediumPublished Jul 29, 2026· AI-analyzed Aug 3, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Penumbra, Inc. has initiated a Class II recall for the Penumbra System RED 68 Reperfusion Catheter (REF: RED68KIT) due to manufacturing issues that may lead to catheter fractures.

Who it affects

This affects Penumbra, Inc., healthcare facilities utilizing reperfusion catheters, and departments responsible for medical device procurement, quality control, and neuro-interventional procedures.

Why it matters

A product fracture in a reperfusion catheter represents a significant mechanical failure during clinical use. Because the source identifies 'manufacturing issues' as the root cause, this suggests a potential gap in production quality controls or material integrity verification that requires remediation to prevent recurrence.

Practical takeaway

QA and manufacturing teams should review current production and inspection records for this specific reference number (RED68KIT) to identify any deviations. Regulatory teams should monitor for updated field safety notices or specific lot-level information as this ongoing recall progresses.

FDA source material

Class II. Reason: Due to manufacturing issues, reperfusion catheters may fractures. Product: Penumbra System RED 68 Reperfusion Catheter REF: RED68KIT. Firm: Penumbra, Inc. (Livermore CA United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.